–(BUSINESS WIRE)–#Remidio–Eyenuk, Inc., headquartered in Los Angeles, California, is an AI diagnostic company focused on quickly and accurately identifying patients suffering from potentially blinding eye diseases and chronic diseases at the point o…
Author: Business Wire
Second Sight Appoints Gregg Williams as Chairman of the Board of Directors
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today announced that the Board of Directors has appointed Mr. Gregg Williams as Chairman of the Board, effective immediately. Mr. Williams, a current member of the Board of Directors of Second Sight and the Company’s largest
Global Fundus Camera (Mydriatic, Non-Mydriatic, Others) Market 2018-2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Fundus Camera Market By Type, By End User, By Portability, By Region, By Country (2018 Edition) – Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering. The global market is projected to displ…
Global Fundus Camera (Mydriatic, Non-Mydriatic, Others) Market 2018-2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Fundus Camera Market By Type, By End User, By Portability, By Region, By Country (2018 Edition) – Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering. The global market is projected to displ…
Global Fundus Camera (Mydriatic, Non-Mydriatic, Others) Market 2018-2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Fundus Camera Market By Type, By End User, By Portability, By Region, By Country (2018 Edition) – Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering. The global market is projected to displ…
Global Ophthalmics Partnering Report 2012-2018: Deal Trends, Players and Financials – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmics Partnering 2012-2018: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Global Ophthalmics Partnering 2012 to 2018 provides the full collection of Ophthalmi…
Global Ophthalmics Partnering Report 2012-2018: Deal Trends, Players and Financials – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmics Partnering 2012-2018: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Global Ophthalmics Partnering 2012 to 2018 provides the full collection of Ophthalmi…
Global Ophthalmics Partnering Report 2012-2018: Deal Trends, Players and Financials – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmics Partnering 2012-2018: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Global Ophthalmics Partnering 2012 to 2018 provides the full collection of Ophthalmi…
BioTime Reports Fourth Quarter and Fiscal 2017 Results
ALAMEDA, Calif.–(BUSINESS WIRE)–BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today reported financial results for the fourth quarter and fiscal year ended December 31, 2017. “2017 was a successful year for BioTime, capped by our recent European CE Mark submission of Renevia® and approval by the DSMB to proceed with the initiation of Cohort 4 of the OpRegen® clinical trial,” said Adi Mohanty, Co-Chief Executive Officer of BioTime.
Asia-Pacific Uveitis Therapeutics Markets 2018-2023 – Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Uveitis Therapeutics in Asia-Pacific Markets to 2023 – Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market” report has been added to ResearchAndMarkets.com’s offering. The Asia…
Back of the Eye Disorders, Featuring a Steadily Growing Pipeline, Likely to Witness 7.9% Annualized Growth, Predicts Roots Analysis
LONDON–(BUSINESS WIRE)–#BackoftheEyeDisorders–Back of the Eye Disorders, featuring a steadily growing pipeline, likely to witness 7.9% annualized growth, predicts Roots Analysis.
Compulink Introduces Innovative Mobile Patient Engagement Technology to Increase Revenue at Vision Expo East 2018
THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Compulink introduces innovative mobile patient engagement technology to increase revenue at Vision Expo East 2018.
World Contact Lenses Market Report 2018 – Analysis and Forecast to 2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “World: Contact Lenses – Market Report – Analysis and Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering. The report provides an in-depth analysis of the global contact lenses market. It presents t…
Avedro Announces Agreement with the FDA for the First U.S. Pivotal Phase 3 Trial of an Epi-on Cross-Linking Treatment for Patients with Progressive Keratoconus
WALTHAM, Mass.–(BUSINESS WIRE)–#clinicaltrials–Avedro Announces Agreement with FDA for First U.S. Pivotal Phase 3 Trial of Epi-On Cross-Linking Treatment for Patients with Progressive Keratoconus.
Aerpio Pharmaceuticals to Present at the Oppenheimer 28th Annual Healthcare Conference
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (OTCQB: ARPO), a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, today announced that President and Founder, Joseph Gardner, Ph.D., will present at the Oppenheimer 28th Annual Healthcare Conference on Tuesday, March 20, 2018 at 8:00 a.m. Eastern Time in New York, N.Y. Dr. Gardner will provide a corporate overview and business update. The presentation will be webcast live and may be accessed b
SeniorWell Expands Leadership Team with Executive Hire
CHICAGO–(BUSINESS WIRE)–SeniorWell Expands Leadership Team with Executive Hire, New CEO will expand the company’s footprint and optimize patient experience
Resumen: EyeArt™, el software de detección de retinopatía diabética basado en la inteligencia artificial de Eyenuk Inc. ha sido probado con el dispositivo portátil de imágenes vinculado a un teléfono inteligente en un nuevo estudio que señala el potencial …
LOS ÁNGELES–(BUSINESS WIRE)–EyeArt™, el software de detección de retinopatía diabética basado en la inteligencia artificial de Eyenuk Inc. ha sido probado con el dispositivo portátil de imágenes vinculado a un teléfono inteligente en un nuevo estudio que señala el potencial para la detección retiniana masiva altamente sensible y rentable Eyenuk, Inc., líder en el desarrollo de soluciones avanzadas basadas en inteligencia artificial (IA) clínicamente probadas para la identificación de enfermed
Groundbreaking Research Reveals Accuracy of PerkinElmer’s High Volume NIPT Platform
WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc.: WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the publication of a research study describing the technology behind the Vanadis NIPT system. The article titled “Imaging Single DNA Molecules for High Precision NIPT” is published online on March 14 in Nature Scientific Reports. WHY: Prenatal screening based on cell-free DNA (cfDNA), also referred to as non-invasive prenatal testing (NIPT),
Kala Pharmaceuticals to Present at the Oppenheimer 28th Annual Healthcare Conference
WALTHAM, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals announces that it will present at the Oppenheimer 28th Annual Healthcare Conference in New York, NY.
Glendale Eye Medical Group Partners with Trilogy Eye Medical Group (Acuity Eye Group™)
PASADENA, Calif. & GLENDALE, Calif.–(BUSINESS WIRE)–#acuityeyegroup–Glendale Eye Medical Group partners with Trilogy Eye Medical Group (Acuity Eye Group™).